These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37725119)

  • 21. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
    Ninan I; Kulkarni SK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the cognition impairer MK-801 on learning and memory in mice and rats.
    van der Staay FJ; Rutten K; Erb C; Blokland A
    Behav Brain Res; 2011 Jun; 220(1):215-29. PubMed ID: 21310186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine.
    Ito K; Abekawa T; Koyama T
    Psychopharmacology (Berl); 2006 Aug; 187(3):293-302. PubMed ID: 16850286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
    de Oliveira RV; Dall'Igna OP; Tort AB; Schuh JF; Neto PF; Santos Gomes MW; Souza DO; Lara DR
    Behav Pharmacol; 2005 Mar; 16(2):79-84. PubMed ID: 15767842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.
    Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1992; 107(4):591-4. PubMed ID: 1534911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
    Hesselink MB; Smolders H; De Boer AG; Breimer DD; Danysz W
    Behav Pharmacol; 1999 Feb; 10(1):85-98. PubMed ID: 10780305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the N-methyl-d-aspartate receptor antagonist, MK-801, on spatial memory and influence of the route of administration.
    Svalbe B; Stelfa G; Vavers E; Zvejniece B; Grinberga S; Sevostjanovs E; Pugovics O; Dambrova M; Zvejniece L
    Behav Brain Res; 2019 Oct; 372():112067. PubMed ID: 31276703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
    Brown JW; Rueter LE; Zhang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproate prevents the induction and the expression of MK-801 sensitization.
    Yang PB; Swann AC; Dafny N
    Brain Res; 2002 Nov; 954(2):151-9. PubMed ID: 12414098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats.
    Cole BJ; Klewer M; Jones GH; Stephens DN
    Psychopharmacology (Berl); 1993; 111(4):465-71. PubMed ID: 7870988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice.
    Zhou X; Chen Q; Hu X; Mao S; Kong Y
    Behav Brain Res; 2014 Jan; 258():153-9. PubMed ID: 24149067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex.
    Clow DW; Lee SJ; Hammer RP
    Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
    Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ
    Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
    Kalivas PW; Alesdatter JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):486-95. PubMed ID: 8229779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.